We talked recently about how diabetes is part of a much larger chronic illness community, and that’s a strength we don’t often tap into. Sometimes innovations that can help us PWDs (people with diabetes) come from folks dealing with other conditions too — like a small Minneapolis, MN, firm called Visual Medical, that was formed about two years ago based on one woman’s family ordeal.
Her name is Rachael Jacques and she grew up with…
Read more »
By
MikeH on
August 16, 2012
Three extra lines on an eye chart.
That may not seem like much at first glance (!), but those lines represent a significant step forward in the treatment of a form of diabetic retinopathy known as diabetic macular edema (DME).
In groundbreaking news this week, the Food and Drug Administration cleared the first drug of its kind to treat DME for people with diabetes, called Lucentis from California-based Genentech.
The FDA noted that this drug…
Read more »
Sometimes, diabetes science confuses me.
Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not.
Sodium-glucose transporter (SGLT-2) inhibitors increase insulin production and effectiveness and stop the liver from producing too much glucose. Basically, they work by spilling glucose over into the urine which leads to less sugar in your bloodstream. The effect: lower BGs and A1Cs.
Sure, it…
Read more »
Happy Saturday! You may experience a little deja vu on this one, as it’s a topic we addressed back in December 2011… about dealing with weight struggles.
Got the dieting blues on these Weighty Matters? We hear you. Please take a gander at this week’s edition of Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
Tim from Washington,…
Read more »
